{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:59:17Z","timestamp":1782809957225,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Seasonal influenza vaccines have proven to be effective against well-matched viruses in healthy adults. However, rapid accumulation of mutations in the main antigenic surface proteins of influenza can compromise the efficiency of flu vaccines. Occasionally, influenza pandemics arise and present a different type of challenge to current seasonal vaccines. Novel vaccination strategies that can educate the host immune system to generate immune responses focusing on conserved epitopes on theses antigenic surface proteins are crucial for controlling and limiting influenza epidemics and pandemics. In this study, we have sequentially vaccinated mice with heterosubtypic influenza HA virus-like particles (VLPs) harboring H1, H8, and H13 from the HA phylogenetic group 1, or H3, H4, and H10 from the HA phylogenetic group 2, or in various combinations. The immunized animals were fully protected when challenged with lethal doses of heterosubtypic viruses from either phylogenetic group. Our vaccination approach demonstrates a promising strategy for the development of a \u2018universal influenza vaccine\u2019.<\/jats:p>","DOI":"10.1038\/s41598-018-22874-w","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T10:35:06Z","timestamp":1520591706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Yuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"22874_CR1","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/35073639","volume":"410","author":"P Piot","year":"2001","unstructured":"Piot, P., Bartos, M., Ghys, P. D., Walker, N. & Schwartlander, B. The global impact of HIV\/AIDS. Nature 410, 968\u2013973 (2001).","journal-title":"Nature"},{"key":"22874_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev.mi.37.100183.002525","volume":"37","author":"RB Couch","year":"1983","unstructured":"Couch, R. B. & Kasel, J. A. Immunity to influenza in man. Annu Rev Microbiol 37, 529\u2013549 (1983).","journal-title":"Annu Rev Microbiol"},{"key":"22874_CR3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1001\/jama.284.13.1655","volume":"284","author":"CB Bridges","year":"2000","unstructured":"Bridges, C. B. et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284, 1655\u20131663 (2000).","journal-title":"JAMA"},{"key":"22874_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","volume":"61","author":"JC de Jong","year":"2000","unstructured":"de Jong, J. C., Beyer, W. E., Palache, A. M., Rimmelzwaan, G. F. & Osterhaus, A. D. Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61, 94\u201399 (2000).","journal-title":"J Med Virol"},{"key":"22874_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jcv.2009.06.004","volume":"45","author":"D Gatherer","year":"2009","unstructured":"Gatherer, D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 45, 174\u2013178 (2009).","journal-title":"J Clin Virol"},{"key":"22874_CR6","doi-asserted-by":"publisher","first-page":"e1000796","DOI":"10.1371\/journal.ppat.1000796","volume":"6","author":"TT Wang","year":"2010","unstructured":"Wang, T. T. et al. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 6, e1000796 (2010).","journal-title":"PLoS Pathog"},{"key":"22874_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","volume":"31","author":"D Corti","year":"2013","unstructured":"Corti, D. & Lanzavecchia, A. Broadly neutralizing antiviral antibodies. Annu Rev Immunol 31, 705\u2013742 (2013).","journal-title":"Annu Rev Immunol"},{"key":"22874_CR8","doi-asserted-by":"publisher","first-page":"15ra15","DOI":"10.1126\/scitranslmed.3000624","volume":"2","author":"S Khurana","year":"2010","unstructured":"Khurana, S. et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2, 15ra15 (2010).","journal-title":"Sci Transl Med"},{"key":"22874_CR9","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1128\/IAI.70.11.6021-6031.2002","volume":"70","author":"GR Moe","year":"2002","unstructured":"Moe, G. R., Zuno-Mitchell, P., Hammond, S. N. & Granoff, D. M. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains. Infect Immun 70, 6021\u20136031 (2002).","journal-title":"Infect Immun"},{"key":"22874_CR10","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1128\/JVI.01336-12","volume":"86","author":"F Krammer","year":"2012","unstructured":"Krammer, F., Pica, N., Hai, R., Tan, G. S. & Palese, P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. J Virol 86, 10302\u201310307 (2012).","journal-title":"J Virol"},{"key":"22874_CR11","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","volume":"183","author":"JH Kim","year":"2009","unstructured":"Kim, J. H., Skountzou, I., Compans, R. & Jacob, J. Original antigenic sin responses to influenza viruses. J Immunol 183, 3294\u20133301 (2009).","journal-title":"J Immunol"},{"key":"22874_CR12","doi-asserted-by":"publisher","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","volume":"7","author":"SF Andrews","year":"2015","unstructured":"Andrews, S. F. et al. Immune history profoundly affects broadly protective B cell responses to influenza. Sci Transl Med 7, 316ra192 (2015).","journal-title":"Sci Transl Med"},{"key":"22874_CR13","doi-asserted-by":"publisher","first-page":"15798","DOI":"10.1073\/pnas.1409171111","volume":"111","author":"SL Linderman","year":"2014","unstructured":"Linderman, S. L. et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013\u20132014 influenza season. Proc Natl Acad Sci USA 111, 15798\u201315803 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"22874_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1089\/vim.2005.18.244","volume":"18","author":"JM Galarza","year":"2005","unstructured":"Galarza, J. M., Latham, T. & Cupo, A. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral immunology 18, 244\u2013251 (2005).","journal-title":"Viral immunology"},{"key":"22874_CR15","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","volume":"25","author":"RA Bright","year":"2007","unstructured":"Bright, R. A. et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25, 3871\u20133878 (2007).","journal-title":"Vaccine"},{"key":"22874_CR16","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1128\/JVI.02052-06","volume":"81","author":"F-S Quan","year":"2007","unstructured":"Quan, F.-S., Huang, C., Compans, R. W. & Kang, S.-M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. Journal of virology 81, 3514\u20133524 (2007).","journal-title":"Journal of virology"},{"key":"22874_CR17","doi-asserted-by":"publisher","first-page":"11813","DOI":"10.1128\/JVI.01076-08","volume":"82","author":"B-Z Wang","year":"2008","unstructured":"Wang, B.-Z. et al. Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. Journal of virology 82, 11813\u201311823 (2008).","journal-title":"Journal of virology"},{"key":"22874_CR18","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1128\/JVI.00641-13","volume":"87","author":"F Krammer","year":"2013","unstructured":"Krammer, F., Pica, N., Hai, R., Margine, I. & Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of virology 87, 6542\u20136550 (2013).","journal-title":"Journal of virology"},{"key":"22874_CR19","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1128\/JVI.01715-13","volume":"87","author":"I Margine","year":"2013","unstructured":"Margine, I. et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. Journal of virology 87, 10435\u201310446 (2013).","journal-title":"Journal of virology"},{"key":"22874_CR20","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1128\/JVI.03004-13","volume":"88","author":"F Krammer","year":"2014","unstructured":"Krammer, F. et al. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets. Journal of virology 88, 3432\u20133442 (2014).","journal-title":"Journal of virology"},{"key":"22874_CR21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","volume":"166","author":"A Escolano","year":"2016","unstructured":"Escolano, A. et al. Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice. Cell 166, 1445\u20131458 (2016). e1412.","journal-title":"Cell"},{"key":"22874_CR22","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1128\/JVI.78.14.7392-7399.2004","volume":"78","author":"A Reyes-Sandoval","year":"2004","unstructured":"Reyes-Sandoval, A. et al. Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. Journal of virology 78, 7392\u20137399 (2004).","journal-title":"Journal of virology"},{"key":"22874_CR23","doi-asserted-by":"publisher","first-page":"e01044","DOI":"10.1128\/mBio.01044-15","volume":"6","author":"LM Schwartzman","year":"2015","unstructured":"Schwartzman, L. M. et al. An intranasal virus-like particle vaccine broadly protects mice from multiple subtypes of influenza A virus. MBio 6, e01044\u201301015 (2015).","journal-title":"MBio"},{"key":"22874_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF00955327","volume":"333","author":"G Majno","year":"1960","unstructured":"Majno, G., La Gattuta, M. & Thompson, T. E. Cellular death and necrosis: chemical, physical and morphologic changes in rat liver. Virchows Arch Pathol Anat Physiol Klin Med 333, 421\u2013465 (1960).","journal-title":"Virchows Arch Pathol Anat Physiol Klin Med"},{"key":"22874_CR25","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1128\/JVI.74.9.3996-4003.2000","volume":"74","author":"GE Price","year":"2000","unstructured":"Price, G. E., Gaszewska-Mastarlarz, A. & Moskophidis, D. The role of alpha\/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 74, 3996\u20134003 (2000).","journal-title":"J Virol"},{"key":"22874_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/1998\/50472","volume":"5","author":"A Bot","year":"1998","unstructured":"Bot, A., Bot, S., Garcia-Sastre, A. & Bona, C. Protective cellular immunity against influenza virus induced by plasmid inoculation of newborn mice. Dev Immunol 5, 197\u2013210 (1998).","journal-title":"Dev Immunol"},{"key":"22874_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.7150\/ijbs.4874","volume":"8","author":"M Rincon","year":"2012","unstructured":"Rincon, M. & Irvin, C. G. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 8, 1281\u20131290 (2012).","journal-title":"Int J Biol Sci"},{"key":"22874_CR28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annual review of immunology 30, 429\u2013457 (2012).","journal-title":"Annual review of immunology"},{"key":"22874_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/jtbi.1993.1139","volume":"164","author":"TB Kepler","year":"1993","unstructured":"Kepler, T. B. & Perelson, A. S. Somatic hypermutation in B cells: an optimal control treatment. Journal of theoretical biology 164, 37\u201364 (1993).","journal-title":"Journal of theoretical biology"},{"key":"22874_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/0092-8674(82)90202-1","volume":"28","author":"N Green","year":"1982","unstructured":"Green, N. et al. Immunogenic structure of the influenza virus hemagglutinin. Cell 28, 477\u2013487 (1982).","journal-title":"Cell"},{"key":"22874_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","volume":"8","author":"IA Wilson","year":"1990","unstructured":"Wilson, I. A. & Cox, N. J. Structural basis of immune recognition of influenza virus hemagglutinin. Annual review of immunology 8, 737\u2013787 (1990).","journal-title":"Annual review of immunology"},{"key":"22874_CR32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.1124513","volume":"312","author":"J Stevens","year":"2006","unstructured":"Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. science 312, 404\u2013410 (2006).","journal-title":"science"},{"key":"22874_CR33","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"22874_CR34","doi-asserted-by":"publisher","first-page":"e00018","DOI":"10.1128\/mBio.00018-10","volume":"1","author":"J Steel","year":"2010","unstructured":"Steel, J. et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1, e00018\u201300010 (2010).","journal-title":"MBio"},{"key":"22874_CR35","doi-asserted-by":"publisher","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","volume":"5","author":"RH Friesen","year":"2010","unstructured":"Friesen, R. H. et al. New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLos one 5, e9106 (2010).","journal-title":"PLos one"},{"key":"22874_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"22874_CR37","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"J Sui","year":"2009","unstructured":"Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nature structural & molecular biology 16, 265\u2013273 (2009).","journal-title":"Nature structural & molecular biology"},{"key":"22874_CR38","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"22874_CR39","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"22874_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","volume":"14","author":"G Nakamura","year":"2013","unstructured":"Nakamura, G. et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell host & microbe 14, 93\u2013103 (2013).","journal-title":"Cell host & microbe"},{"key":"22874_CR41","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1128\/JVI.00178-14","volume":"88","author":"A Wyrzucki","year":"2014","unstructured":"Wyrzucki, A. et al. Alternative recognition of the conserved stem epitope in influenza A virus hemagglutinin by a VH3-30-encoded heterosubtypic antibody. Journal of virology 88, 7083\u20137092 (2014).","journal-title":"Journal of virology"},{"key":"22874_CR42","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1128\/JVI.03069-14","volume":"89","author":"A Wyrzucki","year":"2015","unstructured":"Wyrzucki, A., Bianchi, M., Kohler, I., Steck, M. & Hangartner, L. Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies. Journal of virology 89, 3136\u20133144 (2015).","journal-title":"Journal of virology"},{"key":"22874_CR43","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nature communications 6 (2015).","DOI":"10.1038\/ncomms8708"},{"key":"22874_CR44","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI74374","volume":"125","author":"CJH Dunand","year":"2015","unstructured":"Dunand, C. J. H. et al. Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. The Journal of clinical investigation 125, 1255\u20131268 (2015).","journal-title":"The Journal of clinical investigation"},{"key":"22874_CR45","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1073\/pnas.79.15.4800","volume":"79","author":"M Krystal","year":"1982","unstructured":"Krystal, M., Elliott, R. M., Benz, E. W., Young, J. F. & Palese, P. Evolution of influenza A and Bviruses: conservation of structural features in the hemagglutinin genes. Proceedings of the National Academy of Sciences 79, 4800\u20134804 (1982).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"22874_CR46","doi-asserted-by":"publisher","first-page":"13434","DOI":"10.1128\/JVI.01429-12","volume":"86","author":"G Bommakanti","year":"2012","unstructured":"Bommakanti, G. et al. Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge. Journal of virology 86, 13434\u201313444 (2012).","journal-title":"Journal of virology"},{"key":"22874_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1073\/pnas.1308701110","volume":"111","author":"Y Lu","year":"2014","unstructured":"Lu, Y., Welsh, J. P. & Swartz, J. R. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proceedings of the National Academy of Sciences 111, 125\u2013130 (2014).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"22874_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"22874_CR49","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1126\/science.341.6151.1171","volume":"341","author":"J Cohen","year":"2013","unstructured":"Cohen, J. A Once-in-a-Lifetime Flu Shot? Science 341, 1171\u20131171 (2013).","journal-title":"Science"},{"key":"22874_CR50","doi-asserted-by":"publisher","first-page":"13701","DOI":"10.1073\/pnas.1007465107","volume":"107","author":"G Bommakanti","year":"2010","unstructured":"Bommakanti, G. et al. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge. Proceedings of the National Academy of Sciences 107, 13701\u201313706 (2010).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"22874_CR51","doi-asserted-by":"publisher","first-page":"E2514","DOI":"10.1073\/pnas.1402766111","volume":"111","author":"VV Mallajosyula","year":"2014","unstructured":"Mallajosyula, V. V. et al. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection. Proceedings of the National Academy of Sciences 111, E2514\u2013E2523 (2014).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"22874_CR52","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1128\/JVI.00093-16","volume":"90","author":"JE Bryant","year":"2016","unstructured":"Bryant, J. E. et al. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A\/H1N1 Virus Infection during the 2009 Pandemic. Journal of virology 90, 6549\u20136556 (2016).","journal-title":"Journal of virology"},{"key":"22874_CR53","doi-asserted-by":"publisher","first-page":"e13972","DOI":"10.1371\/journal.pone.0013972","volume":"5","author":"BZ Wang","year":"2010","unstructured":"Wang, B. Z. et al. Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection. PLoS One 5, e13972 (2010).","journal-title":"PLoS One"},{"key":"22874_CR54","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2016.05.021","volume":"233","author":"T Mohan","year":"2016","unstructured":"Mohan, T. et al. Co-delivery of GPI-anchored CCL28 and influenza HA in chimeric virus-like particles induces cross-protective immunity against H3N2 viruses. J Control Release 233, 208\u2013219 (2016).","journal-title":"J Control Release"},{"key":"22874_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep40226","volume":"7","author":"T Mohan","year":"2017","unstructured":"Mohan, T. et al. Chimeric virus-like particles containing influenza HA antigen and GPI-CCL28 induce long-lasting mucosal immunity against H3N2 viruses. Sci Rep 7, 40226 (2017).","journal-title":"Sci Rep"},{"key":"22874_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.vetmic.2012.11.035","volume":"162","author":"J-G Choi","year":"2013","unstructured":"Choi, J.-G. et al. Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens. Veterinary microbiology 162, 623\u2013630 (2013).","journal-title":"Veterinary microbiology"},{"key":"22874_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02725-4","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng, L. et al. Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nat Commun 9, 359 (2018).","journal-title":"Nat Commun"},{"key":"22874_CR58","doi-asserted-by":"publisher","first-page":"e30152","DOI":"10.1371\/journal.pone.0030152","volume":"7","author":"DL Glauser","year":"2012","unstructured":"Glauser, D. L., Kratz, A.-S. & Stevenson, P. G. Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion. PLoS One 7, e30152 (2012).","journal-title":"PLoS One"},{"key":"22874_CR59","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1016\/j.vaccine.2015.01.086","volume":"33","author":"DG Koutsonanos","year":"2015","unstructured":"Koutsonanos, D. G. et al. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts. Vaccine 33, 4675\u20134682 (2015).","journal-title":"Vaccine"},{"key":"22874_CR60","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.vaccine.2013.01.041","volume":"31","author":"T Mohan","year":"2013","unstructured":"Mohan, T., Sharma, C., Bhat, A. A. & Rao, D. N. Modulation of HIV peptide antigen specific cellular immune response by synthetic alpha- and beta-defensin peptides. Vaccine 31, 1707\u20131716 (2013).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22874-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22874-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22874-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:34:01Z","timestamp":1671593641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22874-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22874"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22874-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4577"}}